For research use only. Not for therapeutic Use.
Selegiline-D5, also known as Deprenyl-D5, is a deuterated form of selegiline, where five hydrogen atoms are replaced with deuterium. Selegiline is a selective monoamine oxidase-B (MAO-B) inhibitor used in the treatment of Parkinson’s disease and major depressive disorder. The deuterated version, Selegiline-D5, is used in research to study the drug’s pharmacokinetics, metabolism, and interactions in the body. The incorporation of deuterium atoms provides a stable isotopic label, which helps in tracking the compound more accurately in mass spectrometry and other analytical techniques.
Catalog Number | M090080 |
CAS Number | 1217705-21-9 |
Synonyms | Selegiline-D5/Deprenyl-D5 |
Molecular Formula | C13H18ClN |
Purity | ≥95% |
Storage | -20°C |
IUPAC Name | (2R)-N-methyl-1-(2,3,4,5,6-pentadeuteriophenyl)-N-prop-2-ynylpropan-2-amine;hydrochloride |
InChI | InChI=1S/C13H17N.ClH/c1-4-10-14(3)12(2)11-13-8-6-5-7-9-13;/h1,5-9,12H,10-11H2,2-3H3;1H/t12-;/m1./s1/i5D,6D,7D,8D,9D; |
InChIKey | IYETZZCWLLUHIJ-AAQPRKMGSA-N |
SMILES | CC(CC1=CC=CC=C1)N(C)CC#C.Cl |